Free Trial

Enzo Biochem (ENZ) SEC Filings & 10K Form

Enzo Biochem logo
$0.29 -0.02 (-7.72%)
Closing price 03:58 PM Eastern
Extended Trading
$0.29 0.00 (0.00%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Enzo Biochem SEC Filings

DateFilerForm TypeView
03/17/2025
3:15 PM
Enzo Biochem (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/17/2025
3:44 PM
COUCHMAN JONATHAN (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
3:44 PM
Enzo Biochem (Issuer)
PULLY STEVEN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
3:44 PM
Enzo Biochem (Issuer)
Radoff Bradley Louis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:44 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:32 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:16 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:15 PM
Enzo Biochem (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/02/2024
3:15 PM
COUCHMAN JONATHAN (Reporting)
Enzo Biochem (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2024
12:02 PM
Enzo Biochem (Filer)
Form ARS
11/27/2024
3:15 PM
Enzo Biochem (Filer)
Form DEF 14A
10/29/2024
7:02 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
4:04 PM
Enzo Biochem (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/24/2024
4:19 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
4:22 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
4:23 PM
Eckert Patricia (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
6:50 PM
Cannon Kara (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:13 PM
Enzo Biochem (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/24/2024
3:44 PM
Enzo Biochem (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:46 PM
Cannon Kara (Reporting)
Enzo Biochem (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:ENZ) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners